BioForce Nanosciences Holdings, Inc. Stock Other OTC
Equities
BFNH
US09064C2061
Other Specialty Retailers
Sales 2022 | - | Sales 2023 | - | Capitalization | 58.84M 80.11M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net Debt 2022 | 173K 236K | Net Debt 2023 | 220K 300K | EV / Sales 2023 | - |
P/E ratio 2022 |
-120
x | P/E ratio 2023 |
-101
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 14.4% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Gagnon
CEO | Chief Executive Officer | 62 | 21-11-29 |
John LaViolette
CEO | Chief Executive Officer | 62 | 21-11-29 |
Sasha Shapiro
PSD | President | 61 | 21-11-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Merle Ferguson
CHM | Chairman | 76 | 13-07-07 |
Richard Kaiser
DFI | Director of Finance/CFO | 59 | 13-06-30 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 843M | |
0.00% | 666M | |
+31.69% | 474M | |
0.00% | 135M | |
+97.83% | 53.91M |